Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2018 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2018 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction

  • Authors:
    • De‑Lei Cheng
    • Nan Zhu
    • Hao Xu
    • Cheng‑Li Li
    • Wei‑Fu Lv
    • Wei‑Wei Fang
    • Chuan‑Ting Li
  • View Affiliations / Copyright

    Affiliations: Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong 250021, P.R. China, Department of Radiology, People's Hospital of Wuhe County, Bengbu, Anhui 233300, P.R. China, Department of Interventional Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221100, P.R. China, Department of Interventional Radiology, Anhui Provincial Hospital, Hefei, Anhui 230000, P.R. China
    Copyright: © Cheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4141-4149
    |
    Published online on: September 7, 2018
       https://doi.org/10.3892/etm.2018.6708
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

To date, interventional therapy for patients with Budd-Chiari syndrome (BCS) due to hepatic vein obstruction (HVO) has not been standardized in China. In Western countries, BCS primarily occurs due to thrombosis and the majority of patients receive thrombolysis. In China, BCS is mostly caused by the membranous occlusion of the HV or IVC. The present retrospective study evaluated the efficacy of recanalization techniques in patients with primary BCS due to HVO. The data of 69 patients with BCS due to HVO, who underwent endovascular therapy at 2 centers in China between December 2010 and December 2012, were analyzed. All of the patients underwent balloon angioplasty. In addition, 14, 6 and 5 patients received thrombolysis, endovascular stent and thrombolysis + endovascular stent, respectively. The overall technical success rate was 95.7% (66/69), and was comparable among the treatments. The HV pressure after the treatments was significantly lower compared with that prior to the procedures (23.3±6.9 vs. 46.5±8.6 cmH2O; P<0.001). The mean follow‑up duration was 75 months (range, 60‑84 months). During the 5‑year follow‑up, 10 patients (15.2%) had developed a recurrence of BCS‑associated symptoms, of which 7 were successfully treated. The cumulative survival rates at 12, 36 and 60 months after endovascular interventional therapy (balloon angioplasty or combined treatment) were 98.5, 98.5 and 93.9%, respectively. After treatment by endovascular therapy, the patients with BCS caused by HVO had high survival rates and low recurrence rates in the short‑ and mid‑term.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Martens P and Nevens F: Budd-Chiari syndrome. United European Gastroenterol J. 3:489–500. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Pons Colon JP, Kim D, Xu Y, Wu FY, Han S, et al: Redefining Budd-Chiari syndrome: A systematic review. World J Hepatol. 8:691–702. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Goel RM, Johnston EL, Patel KV and Wong T: Budd-Chiari syndrome: Investigation, treatment and outcomes. Postgrad Med J. 91:692–697. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Cui YF, Fu YF, Li DC and Xu H: Percutaneous recanalization for HV-type Budd-Chiari syndrome: Long-term patency and survival. Hepatol Int. 10:363–369. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Akamatsu N, Sugawara Y and Kokudo N: Budd-Chiari syndrome and liver transplantation. Intractable Rare Dis Res. 4:24–32. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Murad Darwish S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, et al: Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 151:167–175. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Sang HF and Li XQ: Endovascular treatment of Budd-Chiari syndrome with HV obstruction in China. J Laparoendosc Adv Surg Tech A. 24:846–851. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, et al: Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 57:1962–1968. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K and Brountzos E: Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: Results from a single center. Cardiovasc Intervent Radiol. 37:691–697. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, Chen F, Mangat K, Elias E and Olliff S: Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther. 39:864–872. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Cheng D, Xu H, Lu ZJ, Hua R, Qiu H, Du H, Xu X and Zhang J: Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: A single-center study. J Gastroenterol Hepatol. 28:1061–1067. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Qi XS, Ren WR, Fan DM and Han GH: Selection of treatment modalities for Budd-Chiari syndrome in China: A preliminary survey of published literature. World J Gastroenterol. 20:10628–10636. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Cui YF, Fu YF, Wei N, Zhu HC and Xu H: Retrograde puncture assisted HV recanalization in treating Budd-Chiari syndrome with segmental obstruction of hepatic venous. Radiol Med. 120:1184–1189. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Kumar Shalimar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, Thakur B and Acharya SK: Hepatic venous outflow tract obstruction: Treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther. 43:1154–1167. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Meng X, Lv Y, Zhang B, He C, Guo W, Luo B, Yin Z, Fan D and Han G: Endovascular management of Budd-Chiari syndrome with IVC thrombosis: A 14-year single-center retrospective report of 55 patients. J Vasc Interv Radiol. 27:1592–1603. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Huang Q, Shen B, Zhang Q, Xu H, Zu M, Gu Y, Wei N, Cui Y and Huang R: Comparison of long-term outcomes of endovascular management for membranous and segmental IVC obstruction in patients with primary Budd-Chiari syndrome. Circ Cardiovasc Interv. 9:e0031042016. View Article : Google Scholar : PubMed/NCBI

17 

Zhang Q, Xu H, Zu M, Gu Y, Wei N, Wang W, Gao Z and Shen B: Catheter-directed thrombolytic therapy combined with angioplasty for hepatic venous obstruction in Budd-Chiari syndrome complicated by thrombosis. Exp Ther Med. 6:1015–1021. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Siriwardana RC, Niriella MA, Dassanayake AS, Liyanage C, Gunathilaka B, Jayathunge S and de Silva HJ: Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: A prospective study. Hepatobiliary Pancreat Dis Int. 14:401–405. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Tang W, Zhang XM, Yang L, Mitchell DG, Zeng NL and Zhai ZH: Hepatic caudate vein in Budd-Chiari syndrome: Depiction byusing magnetic resonance imaging. Eur J Radiol. 77:143–148. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Mukund A and Gamanagatti S: Imaging and interventions in Budd-Chiari syndrome. World J Radiol. 3:169–177. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Gao Y, Chen S and Yu C: Applicability of different endovascular methods for treatment of refractory Budd-Chiari syndrome. Cell Biochem Biophys. 61:453–460. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Fan X, Liu K, Che Y, Wang S, Wu X, Cao J and Li J: Good clinical outcomes in Budd-Chiari syndrome with hepatic venous occlusion. Dig Dis Sci. 61:3054–3060. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Hanaoka J, Shimada M, Uchiyama H, Ikegami T, Imura S, Morine Y and Kanemura H: A simple formula to calculate the liver drainage volume of the accessory right HV using its diameter alone. Surgery. 146:264–268. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Miraglia R, Maruzzelli L and Luca A: Recanalization of occlusive transjugular intrahepatic portosystemic shunts inaccessible to the standard transvenous approach. Diagn Interv Radiol. 19:61–65. 2013.PubMed/NCBI

25 

Gupta AC, Wang W, Shah C, Sands MJ, Bullen J, Remer EM, Bayona PM, Carey W and Kapoor B: Added value of covered stents in transjugular intrahepatic portosystemic shunt: A large single-center experience. Cardiovasc Intervent Radiol. 40:1723–1731. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S and Elias E: Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 55:878–884. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Valla D, Hadengue A, el Younsi M, Azar N, Zeitoun G, Boudet MJ, Molas G, Belghiti J, Erlinger S, Hay JM and Benhamou JP: Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology. 25:814–819. 1997. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cheng DL, Zhu N, Xu H, Li CL, Lv WF, Fang WW and Li CT: Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction. Exp Ther Med 16: 4141-4149, 2018.
APA
Cheng, D., Zhu, N., Xu, H., Li, C., Lv, W., Fang, W., & Li, C. (2018). Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction. Experimental and Therapeutic Medicine, 16, 4141-4149. https://doi.org/10.3892/etm.2018.6708
MLA
Cheng, D., Zhu, N., Xu, H., Li, C., Lv, W., Fang, W., Li, C."Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction". Experimental and Therapeutic Medicine 16.5 (2018): 4141-4149.
Chicago
Cheng, D., Zhu, N., Xu, H., Li, C., Lv, W., Fang, W., Li, C."Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction". Experimental and Therapeutic Medicine 16, no. 5 (2018): 4141-4149. https://doi.org/10.3892/etm.2018.6708
Copy and paste a formatted citation
x
Spandidos Publications style
Cheng DL, Zhu N, Xu H, Li CL, Lv WF, Fang WW and Li CT: Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction. Exp Ther Med 16: 4141-4149, 2018.
APA
Cheng, D., Zhu, N., Xu, H., Li, C., Lv, W., Fang, W., & Li, C. (2018). Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction. Experimental and Therapeutic Medicine, 16, 4141-4149. https://doi.org/10.3892/etm.2018.6708
MLA
Cheng, D., Zhu, N., Xu, H., Li, C., Lv, W., Fang, W., Li, C."Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction". Experimental and Therapeutic Medicine 16.5 (2018): 4141-4149.
Chicago
Cheng, D., Zhu, N., Xu, H., Li, C., Lv, W., Fang, W., Li, C."Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction". Experimental and Therapeutic Medicine 16, no. 5 (2018): 4141-4149. https://doi.org/10.3892/etm.2018.6708
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team